Shots:
- Alcon has entered into a non-exclusive collaboration with RxSight to jointly develop adjustable presbyopia-correcting intraocular lenses (PCIOLs)
- Under the collaboration, RxSight & Alcon will combine RxSight’s post-operative light-adjustable technology with Alcon’s PCIOL optical designs to co-develop adjustable PCIOLs for optimized cataract surgery outcomes
- As per the deal, RxSight will lead development & manufacturing, receiving $60M upfront, up to $140M in development & regulatory milestones, plus royalties, while Alcon will lead global commercialization
Ref: Globenewswire | Image: Alcon & RxSight | Press Release
Related News: Alcon to Acquire STAAR Surgical Company for ~$1.5B
PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with usatconnect@pharmashots.com
